Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced five presentations at the 2024 Neuromuscular Study Group (NMSG) Annual Scientific Meeting being held in Tarrytown, N.Y., September 20-22.
Posters will highlight findings from studies evaluating investigational ND0612 in Parkinson's disease and RADICAVA ORS ® (edaravone) in ALS JERSEY CITY, N.J., Sept. 12, 2024 /PRNewswire/ -- Mitsubishi ...
On Thursday, Beijing Tiantan Hospital, which is affiliated to Capital Medical University, announced the foundation of a joint laboratory of Amyotrophic Lateral Sclerosi(ALS) during the 2024 China Inte ...
Much progress has been made in understanding how the disease causes nerve damage at a molecular level. Unfortunately, ALS is, at this time, incurable, although there are treatments to slow progression ...
Much progress has been made in understanding how the disease causes nerve damage at a molecular level. Unfortunately, ALS is, at this time, incurable, although there are treatments to slow progression ...